Interaction between reverse transcriptase and integrase is required for reverse transcription during HIV-1 replication

Journal of Virology

Volumn 89, Issue 23, 2015, Pages 12058-12069

  Tekeste, Shewit S ^a   Wilkinson, Thomas A ^a   Weiner, Ethan M ^b   Xu, Xiaowen ^a   Miller, Jennifer T ^c   Le Grice, Stuart F J ^c   Clubb, Robert T ^b   Chow, Samson A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; COMPLEMENTARY DNA; GLUTAMIC ACID; GLYCINE; INTEGRASE; ISOLEUCINE; RNA DIRECTED DNA POLYMERASE; TRYPTOPHAN; VALINE; PRIMER DNA; PROTEIN BINDING; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME PURIFICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; LIFE CYCLE STAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSE TRANSCRIPTION; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION; ESCHERICHIA COLI; GENETICS; METABOLISM; NUCLEAR MAGNETIC RESONANCE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMINO ACID SUBSTITUTION; BLOTTING, WESTERN; DNA PRIMERS; ESCHERICHIA COLI; HIV INTEGRASE; HIV REVERSE TRANSCRIPTASE; HIV-1; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; VIRUS REPLICATION;

EID: 84949681792     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01471-15     Document Type: Article

References (80)

1. Hill M, Tachedjian G, Mak J. 2005. The packaging and maturation of the HIV-1 Pol proteins. Curr HIV Res 3:73-85. http://dx.doi.org/10.2174/1570162052772942.
2. Telesnitsky A, GoffSP. 1997. Reverse transcriptase and the generation of retroviral DNA, p 121-160. In Coffin JM, Hughes SH, Varmus HE (ed), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor Laboratory, NY.
3. Hu WS, Hughes SH. 2012. HIV-1 reverse transcription. Cold Spring Harb Perspect Med 2:a006882. http://dx.doi.org/10.1101/cshperspect.a006882.
4. Jacobo-Molina A, Arnold E. 1991. HIV reverse transcriptase structurefunction relationships. Biochemistry 30:6351-6356. http://dx.doi.org/10.1021/bi00240a001.
5. Engelman A, Mizuuchi K, Craigie R. 1991. HIV-1 DNA integration: mechanism of viralDNAcleavage andDNAstrand transfer. Cell 67:1211-1221.http://dx.doi.org/10.1016/0092-8674(91)90297-C.
6. Li X, Krishnan L, Cherepanov P, Engelman A. 2011. Structural biology of retroviral DNA integration. Virology 411:194-205. http://dx.doi.org/10.1016/j.virol.2010.12.008.
7. Chow SA, Vincent KA, Ellison V, Brown PO. 1992. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science 255:723-726. http://dx.doi.org/10.1126/science.1738845.
8. Hare S, Di Nunzio F, Labeja A, Wang J, Engelman A, Cherepanov P. 2009. Structural basis for functional tetramerization of lentiviral integrase. PLoS Pathog 5:e1000515. http://dx.doi.org/10.1371/journal.ppat.1000515.
9. Hare S, Gupta SS, Valkov E, Engelman A, Cherepanov P. 2010. Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 464:232-236. http://dx.doi.org/10.1038/nature08784.
10. Li M, Mizuuchi M, Burke TR, Jr, Craigie R. 2006. Retroviral DNA integration: reaction pathway and critical intermediates. EMBO J 25: 1295-1304. http://dx.doi.org/10.1038/sj.emboj.7601005.
11. Hare S, Maertens GN, Cherepanov P. 2012. 3'-Processing and strand transfer catalysed by retroviral integrase in crystallo. EMBO J 31:3020-3028.http://dx.doi.org/10.1038/emboj.2012.118.
12. Maertens GN, Hare S, Cherepanov P. 2010. The mechanism of retroviral integration from X-ray structures of its key intermediates. Nature 468: 326-329. http://dx.doi.org/10.1038/nature09517.
13. Bera S, Pandey KK, Vora AC, Grandgenett DP. 2009. Molecular Interactions between HIV-1 integrase and the two viral DNA ends within the synaptic complex that mediates concerted integration. J Mol Biol 389: 183-198. http://dx.doi.org/10.1016/j.jmb.2009.04.007.
14. Faure A, Calmels C, Desjobert C, Castroviejo M, Caumont-Sarcos A, Tarrago-Litvak L, Litvak S, Parissi V. 2005. HIV-1 integrase crosslinked oligomers are active in vitro. Nucleic Acids Res 33:977-986. http://dx.doi.org/10.1093/nar/gki241.
15. Kotova S, Li M, Dimitriadis EK, Craigie R. 2010. Nucleoprotein intermediates in HIV-1 DNA integration visualized by atomic force microscopy. J Mol Biol 399:491-500. http://dx.doi.org/10.1016/j.jmb.2010.04.026.
16. Krishnan L, Engelman A. 2012. Retroviral integrase proteins and HIV-1 DNA integration. J Biol Chem 287:40858-40866. http://dx.doi.org/10.1074/jbc. R112.397760.
17. Wang JY, Ling H, Yang W, Craigie R. 2001. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J 20:7333-7343. http://dx.doi.org/10.1093/emboj/20.24.7333.
18. Cannon PM, Wilson W, Byles E, Kingsman SM, Kingsman AJ. 1994. Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues. J Virol 68:4768-4775.
19. Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R. 1995. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol 69:2729-2736.
20. Engelman A. 1999. In vivo analysis of retroviral integrase structure and function. Adv Virus Res 52:411-426. http://dx.doi.org/10.1016/S0065-3527(08)60309-7.
21. Li X, Koh Y, Engelman A. 2012. Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus. J Virol 86:3861-3879. http://dx.doi.org/10.1128/JVI.06386-11.
22. Lu R, Ghory HZ, Engelman A. 2005. Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase. J Virol 79:10356-10368. http://dx.doi.org/10.1128/JVI.79.16.10356-10368.2005.
23. Lu R, Limon A, Ghory HZ, Engelman A. 2005. Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase. J Virol 79:2493-2505. http://dx.doi.org/10.1128/JVI.79.4.2493-2505.2005.
24. Briones MS, Chow SA. 2010. A new functional role of HIV-1 integrase during uncoating of the viral core. Immunol Res 48:14-26. http://dx.doi.org/10.1007/s12026-010-8164-z.
25. Briones MS, Dobard CW, Chow SA. 2010. Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core. J Virol 84: 5181-5190. http://dx.doi.org/10.1128/JVI.02382-09.
26. Ao Z, Fowke KR, Cohen EA, Yao X. 2005. Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import. Retrovirology 2:62. http://dx.doi.org/10.1186/1742-4690-2-62.
27. Dobard CW, Briones MS, Chow SA. 2007. Molecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription. J Virol 81:10037-10046. http://dx.doi.org/10.1128/JVI.00519-07.
28. Hehl EA, Joshi P, Kalpana GV, Prasad VR. 2004. Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins. J Virol 78:5056-5067. http://dx.doi.org/10.1128/JVI.78.10.5056-5067.2004.
29. Leavitt AD, Robles G, Alesandro N, Varmus HE. 1996. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J Virol 70: 721-728.
30. Masuda T, Planelles V, Krogstad P, Chen ISY. 1995. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J Virol 69: 6687-6696.
31. Shin C-G, Taddeo B, Haseltine WA, Farnet CM. 1994. Genetic analysis of the human immunodeficiency virus type 1 integrase protein. J Virol 68:1633-1642.
32. Tsurutani N, Kubo M, Maeda Y, Ohashi T, Yamamoto N, Kannagi M, Masuda T. 2000. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells. J Virol 74:4795-4806. http://dx.doi.org/10.1128/JVI.74.10.4795-4806.2000.
33. Wu X, Liu H, Xiao H, Conway JA, Hehl E, Kalpana GV, Prasad V, Kappes JC. 1999. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J Virol 73:2126-2135.
34. Zhu K, Dobard C, Chow SA. 2004. Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase. J Virol 78:5045-5055. http://dx.doi.org/10.1128/JVI.78.10.5045-5055.2004.
35. Ikeda T, Nishitsuji H, Zhou X, Nara N, Ohashi T, Kannagi M, Masuda T. 2004. Evaluation of the functional involvement of human immunodeficiency virus type 1 integrase in nuclear import of viral cDNA during acute infection. J Virol 78:11563-11573. http://dx.doi.org/10.1128/JVI.78.21.11563-11573.2004.
36. Jayappa KD, Ao Z, Yang M, Wang J, Yao X. 2011. Identification of critical motifs within HIV-1 integrase required for importin α3 interaction and viral cDNA nuclear import. J Mol Biol 410:847-862. http://dx.doi.org/10.1016/j.jmb.2011.04.011.
37. Woodward CL, Prakobwanakit S, Mosessian S, Chow SA. 2009. Integrase interacts with nucleoporin NUP153 to mediate the nuclear import of human immunodeficiency virus type 1. J Virol 83:6522-6533. http://dx.doi.org/10.1128/JVI.02061-08.
38. Bukovsky A, Gottlinger H. 1996. Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease. J Virol 70:6820-6825.
39. Lu R, Limon A, Devroe E, Silver PA, Cherepanov P, Engelman A. 2004. Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication. J Virol 78:12735-12746. http://dx.doi.org/10.1128/JVI.78.23.12735-12746.2004.
40. Quillent C, Borman AM, Paulous S, Dauguet C, Clavel F. 1996. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. Virology 219:29-36.http://dx.doi.org/10.1006/viro.1996.0219.
41. Taddeo B, Haseltine WA, Farnet CM. 1994. Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration. J Virol 68:8401-8405.
42. Wilkinson TA, Januszyk K, Phillips ML, Tekeste SS, Zhang M, Miller JT, Le Grice SF, Clubb RT, Chow SA. 2009. Identifying and characterizing a functional HIV-1 reverse transcriptase-binding site on integrase. J Biol Chem 284:7931-7939. http://dx.doi.org/10.1074/jbc. M806241200.
43. Nishitsuji H, Hayashi T, Takahashi T, Miyano M, Kannagi M, Masuda T. 2009. Augmentation of reverse transcription by integrase through an interaction with host factor, SIP1/Gemin2 is critical for HIV-1 infection. PLoS One 4:e7825. http://dx.doi.org/10.1371/journal.pone.0007825.
44. Tasara T, Maga G, Hottiger MO, Hubscher U. 2001. HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other. FEBS Lett 507:39-44. http://dx.doi.org/10.1016/S0014-5793(01)02945-3.
45. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. 1986. Production of acquired immunodeficiency syndromeassociated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59:284-291.
46. Fisher CL, Pei GK. 1997. Modification of a PCR-based site-directed mutagenesis method. Biotechniques 23:570-574.
47. Shibagaki Y, Chow SA. 1997. Central core domain of retroviral integrase is responsible for target site selection. J Biol Chem 272:8361-8369. http://dx.doi.org/10.1074/jbc.272.13.8361.
48. Le Grice SF, Gruninger-Leitch F. 1990. Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. Eur J Biochem 187:307-314. http://dx.doi.org/10.1111/j.1432-1033.1990.tb15306.x.
49. Grandgenett DP, Goodarzi G. 1994. Folding of the multidomain human immunodeficiency virus type-I integrase. Protein Sci 3:888-897.
50. Khan M, Garcia-Barrio M, Powell MD. 2001. Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription. J Virol 75:12081-12087. http://dx.doi.org/10.1128/JVI.75.24.12081-12087.2001.
51. Korin YD, Zack JA. 1998. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol 72:3161-3168.
52. Lodi PJ, Ernst JA, Kuszewski J, Hickman AB, Engelman A, Craigie R, Clore GM, Gronenborn AM. 1995. Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry 34:9826-9833. http://dx.doi.org/10.1021/bi00031a002.
53. Goddard TD, Kneller DG. 2008. Sparky 3. University of California, San Francisco, CA.
54. Schrodinger LLC. 2012. The PyMOL molecular graphics system, version 1.5.0.5. Schrodinger, LLC, New York, NY.
55. Chow SA. 1997. In vitro assays for activities of retroviral integrase. Methods 12:306-317. http://dx.doi.org/10.1006/meth.1997.0484.
56. Ding J, Das K, Hsiou Y, Sarafianos SG, Clark AD, Jr, Jacobo-Molina A, Tantillo C, Hughes SH, Arnold E. 1998. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 Å resolution. J Mol Biol 284:1095-1111. http://dx.doi.org/10.1006/jmbi.1998.2208.
57. Jacobo-Molina A, Ding J, Nanni RG, Clark AD, Jr, Lu X, Tantillo C, Williams RL, Kamer G, Ferris AL, Clark P, et al. 1993. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc Natl Acad Sci U S A 90:6320-6324. http://dx.doi.org/10.1073/pnas.90.13.6320.
58. Patel PH, Jacobo-Molina A, Ding J, Tantillo C, Clark AD, Jr, Raag R, Nanni RG, Hughes SH, Arnold E. 1995. Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase. Biochemistry 34:5351-5363. http://dx.doi.org/10.1021/bi00016a006.
59. Zuiderweg ER. 2002. Mapping protein-protein interactions in solution by NMR spectroscopy. Biochemistry 41:1-7. http://dx.doi.org/10.1021/bi011870b.
60. Krishnan L, Li X, Naraharisetty HL, Hare S, Cherepanov P, Engelman A. 2010. Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc Natl Acad Sci U S A 107:15910-15915. http://dx.doi.org/10.1073/pnas.1002346107.
61. Lutzke RA, Plasterk RH. 1998. Structure-based mutational analysis of the C-terminalDNAbinding domain of human immunodeficiency virus type 1 integrase: critical residues for protein oligomerization and DNA binding. J Virol 72:4841-4848.
62. Lutzke RA, Vink C, Plasterk RH. 1994. Characterization of the minimal DNA-binding domain of the HIV integrase protein. Nucleic Acids Res 22:4125-4131. http://dx.doi.org/10.1093/nar/22.20.4125.
63. Lian L-Y, Roberts GCK. 1993. Effects of chemical exchange on NMR spectra, p 153-182. In Roberts GCK (ed), NMR of macromolecules: a practical approach. Oxford University Press, Inc., New York, NY.
64. Palmer AG, III, Kroenke CD, Loria JP. 2001. Nuclear magnetic resonance methods for quantifying microsecond-to-millisecond motions in biological macromolecules. Methods Enzymol 339:204-238. http://dx.doi.org/10.1016/S0076-6879(01)39315-1.
65. Mandal D, Feng Z, Stoltzfus CM. 2008. Gag-processing defect of human immunodeficiency virus type 1 integrase E246 and G247 mutants is caused by activation of an overlapping 5' splice site. J Virol 82:1600-1604. http://dx.doi.org/10.1128/JVI.02295-07.
66. Gotte M, Li X, Wainberg MA. 1999. HIV-1 reverse transcription: a brief overview focused on structure-function relationships among molecules involved in initiation of the reaction. Arch Biochem Biophys 365:199-210.http://dx.doi.org/10.1006/abbi.1999.1209.
67. Kati WM, Johnson KA, Jerva LF, Anderson KS. 1992. Mechanism and fidelity of HIV reverse transcriptase. J Biol Chem 267:25988-25997.
68. Klarmann GJ, Schauber CA, Preston BD. 1993. Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro. J Biol Chem 268:9793-9802.
69. Lanchy JM, Ehresmann C, Le Grice SF, Ehresmann B, Marquet R. 1996. Binding and kinetic properties of HIV-1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription. EMBO J 15:7178-7187.
70. Temiz NA, Bahar I. 2002. Inhibitor binding alters the directions of domain motions in HIV-1 reverse transcriptase. Proteins 49:61-70. http://dx.doi.org/10.1002/prot.10183.
71. Hsiou Y, Ding J, Das K, Clark AD, Jr, Hughes SH, Arnold E. 1996. Structure of unliganded HIV-1 reverse transcriptase at 2.7 Å resolution: implications of conformational changes for polymerization and inhibition mechanisms. Structure 4:853-860. http://dx.doi.org/10.1016/S0969-2126(96)00091-3.
72. Rodgers DW, Gamblin SJ, Harris BA, Ray S, Culp JS, Hellmig B, Woolf DJ, Debouck C, Harrison SC. 1995. The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 92:1222-1226. http://dx.doi.org/10.1073/pnas.92.4.1222.
73. Sarafianos SG, Das K, Tantillo C, Clark AD, Jr, Ding J, Whitcomb JM, Boyer PL, Hughes SH, Arnold E. 2001. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J 20: 1449-1461. http://dx.doi.org/10.1093/emboj/20.6.1449.
74. Mohammed KD, Topper MB, Muesing MA. 2011. Sequential deletion of the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic classes of defective HIV-1. J Virol 85:4654-4666. http://dx.doi.org/10.1128/JVI.02374-10.
75. Williams KL, Zhang Y, Shkriabai N, Karki RG, Nicklaus MC, Kotrikadze N, Hess S, Le Grice SF, Craigie R, Pathak VK, Kvaratskhelia M. 2005. Mass spectrometric analysis of the HIV-1 integrasepyridoxal 5'-phosphate complex reveals a new binding site for a nucleotide inhibitor. J Biol Chem 280:7949-7955. http://dx.doi.org/10.1074/jbc. M413579200.
76. Battle DJ, Kasim M, Yong J, Lotti F, Lau CK, Mouaikel J, Zhang Z, Han K, Wan L, Dreyfuss G. 2006. The SMN complex: an assembly machine for RNPs. Cold Spring Harbor Symp Quant Biol 71:313-320. http://dx.doi.org/10.1101/sqb.2006.71.001.
77. Hamamoto S, Nishitsuji H, Amagasa T, Kannagi M, Masuda T. 2006. Identification of a novel human immunodeficiency virus type 1 integrase interactor, Gemin2, that facilitates efficient viral cDNA synthesis in vivo. J Virol 80:5670-5677. http://dx.doi.org/10.1128/JVI.02471-05.
78. Engelman A. 2003. The roles of cellular factors in retroviral integration. Curr Top Microbiol Immunol 281:209-238.
79. Jayappa KD, Ao Z, Wang X, Mouland AJ, Shekhar S, Yang X, Yao X. 2015. Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase protein. J Virol 89:3497-3511. http://dx.doi.org/10.1128/JVI.03347-14.
80. Zheng Y, Ao Z, Wang B, Jayappa KD, Yao X. 2011. Host protein Ku70 binds and protects HIV-1 integrase from proteasomal degradation and is required for HIV replication. J Biol Chem 286:17722-17735. http://dx.doi.org/10.1074/jbc. M110.184739.